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Background: Multi-walled carbon nanotubes (MWCNT)s are suspected to induce pulmonary and pleural cancers
due to their asbestos-like configurations. Therefore, accurate measurement of inhaled nanotubes in target organs is
crucial for assessing cancer risk. Conventionally, nanotubes are measured after combustion at high temperature for
conversion into CO2; however, the sensitivity is poor and the method lacks versatility. We have therefore developed
a novel approach using hybrid markers for nanotube analysis, featuring high sensitivity and the capacity to conduct
repeated analyses. The method involves adsorption of markers to nanotubes, followed by their desorption and as-
sessment by means of high performance liquid chromatography (HPLC).
Methods: Recovery of MWCNT from rat lungs was conducted, and pulmonary MWCNT amounts were determined
using rats intratracheally-exposed to MWCNT aerosol at 5 mg/m3 for 6 hours/day.
Results: The correlation coefficient for the calibration curve of MWCNT weight and the HPLC area was 0.9991.
Consequently, the lower quantitation limit yielded was 0.2 μg. The recovery was 92-98% at approximately 0.4-2.0 μg
demonstrating that MWCNTs in the lung could be measured accurately and precisely.
Conclusions: We have developed a novel method using a hybrid marker approach for nanotube analysis, featuring
very high sensitivity and the capacity to conduct repeated analyses. We further confirmed correlations between the
amounts of nanotubes and markers and pulmonary nanotube measurement demonstrated that trace amounts
could be detected with values closely relating to the administered dose, verifying that the method is sensitive
and precise.
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Carbon nanotubes were discovered by Iijima in 1991 [1]
and are generally expected to greatly contribute to soci-
ety because of their structure, size, mass, characteristics
as semiconductors, and other electrical properties. How-
ever, multi-walled carbon nanotubes (MWCNT)s, due to
their fiber-like structure [2], are suspected of causing
toxicity resembling that observed with asbestos. In animal
experiments, development of mesothelioma of the periton-
eum has been reported in mice and rats administered* Correspondence: m-onishi@jisha.or.jp
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stated.MWCNT intraperitoneally [3,4], and clearly care needs to
be taken to avoid adverse human exposure. In addition,
CNTs was found to exacerbate murine allergic airway in-
flammation via enhanced activation of T helper cell im-
munity and increased oxidative stress [5].
Therefore, accurate measurement of inhaled nanotubes
in target organs is crucial for assessing cancer risk. Also,
there is a need to investigate possible accumulation of
MWCNT in the lungs after entry through the nasal cavity,
the anticipated exposure route in human cases [6-8]. The
characteristics of MWCNT include insolubility, a fiber-like
structure of carbon chains, and indistinctive optical signals
(excluding specialized regions). For this reason, quan-
titative evaluation of MWCNT cannot be performedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Rather reliance has been placed on weighing and carbon
analysis, which do not necessarily provide high sensitiv-
ity. Conventionally, nanotubes are measured after com-
bustion at high temperature for conversion into CO2;
however, the sensitivity is poor and the method lacks
versatility [12].
Novel methods using hybrid markers are emerging tools
for determinations without the need for weight meas-
urement or carbon analysis. Use of a polycyclic aro-
matic hydrocarbon (PAH) as a marker was reported by
Nakashima et al. [13] with adsorption onto MWCNT
resulting in a fluorescence quenching effect from the op-
tical perspective [14]; however, investigations have not
been conducted on quantitative evaluation of MWCNT
by means of adsorbing PAH as a marker, then desorbing
and measuring the amount of marker. We have selected
benzo[ghi]perylene (B(ghi)P) as a marker, for adsorption
onto dispersed MWCNT, then desorption using an or-
ganic solvent and quantification by HPLC with fluores-
cence spectroscopy [15,16]. We here document our novel
method using the hybrid marker with evidence of its
applicability for measurement of MWCNT in the lungs,
including after a single exposure in rats.
Methods
Test substance
A MWCNT sample was purchased from Hodogaya
Chemical, Co. Ltd. (MWNT-7, Lot No. 080126, Tokyo,
Japan) and used in the present study as produced; i.e.,
without being purified or further sieved. Since MWCNTs
are not water soluble, the test substance was suspended
in 9.6% phosphate-buffered saline containing 0.1% Tween
80 (TW-mixture) as a colloidal dispersant and subjected to
ultrasonication for 20 min with an ultrasonic homogenizer
(VP-30S, 20 kHz, 300 W, TAITEC Co., Ltd, Tokyo, Japan).
Animal
Male F344/DuCrlCrlj rats were purchased from Charles
River Japan, Inc. (Kanagawa, Japan) at the age of 4 weeks
for inhalation exposure and employed at the age of
11 weeks for intratracheal administration and recovery
testing. The animals were quarantined and acclimated for
2 weeks, then housed individually in stainless steel wire-
mesh hanging cages (170W × 294D × 176H mm) under
controlled environmental conditions. For inhalation cham-
bers, the room temperature and the relative humidity were
controlled at 23°C ± 2°C and 55% ± 10% with 12 air
changes/hour. For intratracheal administration, the room
temperature and the relative humidity were controlled at
24°C ± 2°C and 55% ± 10% with 15 to 17 air changes/hour.
Fluorescent lighting was controlled automatically to pro-
vide a 12-hour light/dark cycle. All rats had free access
to sterilized water and γ-irradiation-sterilized commercialpellet diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan).
The animals were cared for in accordance with the Guide
for the Care and Use of Laboratory Animals [17], and the
present study was approved by the ethics committee of the
Japan Bioassay Research Center (JBRC).
Recovery test design
To validate the proposed method, a recovery test was
performed by spiking lung tissue. A total of 5 rats were
employed, and their lungs were removed for the recov-
ery test. The mean and standard deviation (SD) of body
weights were 253.1 ± 12.4 g at the commencement. After
inhalational anesthetization with isoflurane gas (Forane,
Abbott Japan Co., Ltd., Tokyo, Japan), all rats under-
went complete necropsy, when lungs were removed and
weighed. The lungs were fixed in 10% neutral buffered
formalin at 1 week. Then, a TW-mixture solution con-
taining 2 μg of MWCNT was added and the lungs were
measured for MWCNTs as detailed below.
Intratracheal administration test design
A total of 5 rats were used for the intratracheal administra-
tion of MWCNT. The initial body weight mean and SD
were 262.2 ± 11.7 g. Before intratracheal administration,
the ultrasonicated suspension of MWCNTs was further
subjected to additional ultrasonication for 30s with a soni-
cator (US-2, AS ONE Co., Ltd., Tokyo, Japan). After inha-
lational anesthetization with isoflurane gas (Forane, Abbott
Japan Co., Ltd., Tokyo, Japan), the suspension of MWCNT
in TW-mixture (0.3 ml) was intratracheally administrated
[18], using a microspray cannula of an Intratracheal Aero-
solizer (1A-1B, PennCentury, Inc., USA). Rats received
MWCNTs at a dose of 2 μg/animal. At subsequent
complete necropsy, the lungs and trachea were removed,
weighed, and fixed in 10% neutral buffered formalin for
1 week. Then the lungs were assessed for MWCNTs by the
method detailed below.
Inhalation exposure test design
Aerosol generation and whole body inhalation exposure
to MWCNTs: The system and method for generation of
MWCNT aerosols and inhalation exposure of rats to a
dry aerosol in chambers were described in detail earlier
[19]. Twenty five rats were exposed to MWCNT aerosol
at a target concentration of 5 mg/m3 for 6 hours/day.
The mean and SD of body weights were 123.3 ± 6.1 g for
all rats. At the end of the six-hour exposure period,
anesthetization with isoflurane gas was performed for
5 rats for necropsy, and their left lungs were removed,
weighed, fixed in 10% neutral buffered formalin for
1 week and employed for measurement of MWCNT as
detailed below. Groups of five remaining animals were
necropsied on 1, 7, 28 or 56 days after the exposure for
determination of time change in MWCNT deposits.
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A 10 mg sample of MWCNT was added to 40 ml of
TW-mixture and then sonicated during a 30-min cool-
ing period. The solution was diluted to 2 μg/ml with
C99, then 0.4, 0.8, 1.2, 1.6 μg/ml C99 additional solutions
were prepared as further standards, 0.1 ml of each being
used for analysis. The standard solutions were centrifuged
(12000 rpm, 10 min), and the supernatants were removed
and after addition of 0.5 ml of TW-mixture were stirred
and centrifuged.
Acidic preparation
Following removal of the supernatants and addition
of 100 μl concentrated sulfuric acid, the resultant so-




Figure 1 Novel method using hybrid markers for MWCNT. a, Lung exp
temperature. c, Lung digestion in C99. d, Lung solution centrifugation at 1
using hybrid markers: Marker adsorbtion onto MWCNT for 15 min. g, Extrac
(ghi)P in the MWCNT. i, HPLC analysis.membrane filters (Whatman; 111109, pore size; 0.8 μm,
diameter; 47 mm) were extracted under ultrasound with
1 ml of TW-mixture and 0.5 ml aliquots of MWCNT
solution were transferred to glass tubes for HPLC auto-
sample analysis.
Lung digestion
After fixation in 10% neutral buffered formalin for
1 week, lung samples (Figure 1a) were allowed to react
with C99 at room temperature overnight [20] (Figure 1b).
The digested solution (Figure 1c) was then centrifuged at
12,000 rpm for 10 minutes (Figure 1d) and the super-
natant was removed (Figure 1e). A 0.5 ml aliquot of
TW-mixture was added followed by stirring and further
centrifugation and then “acidic preparation” and “noveld
e
f
osed to MWCNT. b, Transfer of lung tissue into C99 at room
2,000 rpm for 10 minutes. e, Supernatant removal. f, Novel method
tion of adsorbed B(ghi)P on MWCNTs to acetonitrile. h, Filtration of B
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performed as described below.
Novel method using hybrid markers and HPLC analysis
After adding 0.125 μg/ml B(ghi)P and 25 μl acetonitrile
solution (Figure 1f), the solutions were stirred for 15 min
to produce MWCNT solutions with actual concentrations
of 0.2, 0.4, 0.6, 0.8, and 1.0 μg/ml. The solutions were then
centrifuged, and the supernatants were removed. After
addition of 0.5 ml D.W., the resultant solutions were
stirred and then centrifuged again. After removal of the
supernatants, addition of 0.5 ml acetonitrile, and stirring
(Figure 1g), the adsorbed B(ghi)P in MWCNTs was ex-
tracted to acetonitrile and filtered (Figure 1h) for HPLC
analysis. Chromatography was performed using an Acquity
UPLC system (Waters, Milford, MA, U.S.A.) coupled to a
fluorescence detector FLR (Waters). Eluates were analyzed
quantitatively by monitoring at fluorescent wavelengths of
294 nm for excitation and 410 nm for emission with 5 ml
aliquots of extract injected onto a 1.7 mm C18 100 ×
2.1 mm I.D. Acquity BEH column (Waters) (Figure 1i).
The mobile phases were acetonitrile : methanol : distilled
water =75 : 20 : 5. The peak of the injected sample was de-
tected at about 1.3 min. An eluent flow rate of 0.5 ml/min
was used for all analyses.
Results and discussion
By treating the lungs removed from rats with formalin
solution (10% neutral buffered formalin) and Clean
99-K200R (C99) in advance, the lungs could be rapidlya b
d
Figure 2 Sample preparation for MWCNT. The lungs were dissolved wit
a, Sample immediately after starting lung dissolution. b, after 5 min. c, afte
lung-dissolved solution. d, Before treatment with sulfuric acid. e, After treatdissolved (within 30 min) (Figure 2a,b and c). With regard
to the analytical method, it was clear that for extrac-
tion of MWCNT from the lungs, dissolution with C99
is markedly faster after immersion in formalin compared
to dissolution with C99 only. Scanning electron micro-
scope (SEM) observation of centrifuge sediments of
lung-dissolved solution, however, revealed MWCNT sur-
rounded by undissolved components (Figure 2d), mainly
connective tissue. The addition of concentrated sulfuric
acid to the sediment led to the complete dissolution of
sediment components other than MWCNTs, and as a re-
sult of subsequent filtration, MWCNTs were isolated as
the only residue (Figure 2e).
MWCNTs, with clean smooth surfaces due to alkali
(C99) and acid (sulfuric acid) treatments, were dispersed
by ultrasonic vibration, and then B(ghi)P was adsorbed
for 15 min, followed by centrifugation and removal of
the supernatant. Finally, the marker was desorbed with
acetonitrile in organic solvent (Figure 3a), and examined
by HPLC. Chromatograms of MWCNT with B(ghi)P re-
vealed a peak at 1.3 min (Figure 3b), no peak being ob-
served with MWCNT alone (Figure 3c); this confirmed
that untreated MWCNT had no B(ghi)P on their sur-
faces. Ten measurements were made to generate a cali-
bration curve of MWCNT, the relationship between the
concentration and area being shown in Figure 3d. Repeated
generation of calibration curves using this method gave
consistently similar values. The lower quantitation limit
yielded was 0.2 μg. The correlation coefficient was 0.9991,
confirming the linearity and reliability of the calibrationc
e
h laboratory bleach (Clean 99-K200R) at room temperature overnight.
r 10 min. SEM images of MWCNTs centrifugally sedimented in the








Figure 3 Adsorption and desorption of the marker (B(ghi)P). a, Processes of adsorbtion onto the surface of the MWCNT and desorption with
organic solvent. b, HPLC chromatogram of MWCNTs with markers. c, HPLC chromatogram of MWCNT without markers. d, Calibration curve of
MWCNT. e, GC-MS mass spectrum of MWCNT with the marker. f, Quenching effects of MWCNT with marker adsorption.
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faces of MWCNT, B(ghi)P-adsorbed MWCNT were dir-
ectly introduced into a mass spectrometer, and the mass
spectrometry measurement revealed peaks at m/z = 276
























Figure 4 Measurement of MWCNT in the lungs of rats administered b(m/z = 276) and a fragment peak (m/z = 138) of B(ghi)P
(Figure 3e). Pale-blue fluorescence was observed upon UV
lamp irradiation of B(ghi)P dissolved in TW solution while
such fluorescence was not seen with B(ghi)P solution con-





























Figure 5 Time-course changes in the amount of MWCNT in the lungs of rats after inhalation exposure. Values are mean ± SD.
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addition of a defined amount of MWCNT to rat lungs re-
moved in advance, collection rates obtained according to
the analytical procedure above confirmed spiked recovery,
measurement accuracy, and repeatability.
Recovery was 92.5% at approximately 0.4 μg, 93.0%
at 1.0 μg, and 98.0% at 2.0 μg, demonstrating that
MWCNTs in the lung could be measured accurately and
precisely. Furthermore, upon intratracheal administra-
tion of 2 μg MWCNT to rats and subsequent measure-
ment of MWCNT with this method, 0.68 μg (34.3%),
0.96 μg (48.5%), and 0.34 μg (17.2%) of MWCNT were
collected from the right lung, left lung, and trachea,
respectively (Figure 4). Although it was possible that
MWCNTs remained in the trachea, the results showed
that almost all the administered tubules could be recov-
ered from the lungs and the trachea and that the amount
could be appropriately measured despite a very low dose.
The fact that the right lung was found to contain more
MWCNTs is consistent with the larger size as compared
to the left lung.
Following the method of Kasai et al. [19], when rats were
exposed to MWCNTs by whole body inhalation exposure,
the amounts of tubules decreased to approximately one
half on day 1 of the post-exposure period, with subsequent
further gradually decrease on days 7, 28, and 56 (Figure 5).
As a result of measuring the amount of MWCNT in the
left lung of rats after a single inhalation exposure, the abso-
lute amount was actually found to be not more than 2 μg
[19]. With the method of Tamura et al. [12], the lower
quantitation limit of MWCNT was thought to be 1 μg, in
contrast to the 0.2 μg established here.
In the future, correlation studies of inhaled CNTs in
the lung and lung inflammatory status should be con-
ducted as this is an important issue for which we could
utilize this method in environmental toxicology.Conclusions
In conclusion, our novel method using hybrid markers
offers a new approach for very accurate measurement of
multi-walled carbon nanotubes. Because of the nature
of the adsorption and desorption processes, weights of
MWCNTs and marker levels directly correlate. Further-
more, our method here proved applicable to measurement
of nanotubes in lungs of animals after administration in
in vitro/in vivo models. The novel method using hybrid
markers provides a platform to study MWCNTs with high
sensitivity and versatility, with the ability to conduct
repeated analyses. This technique should facilitate assess-
ment of nano-bio interactions and carcinogenicity of nano-
tubes. Since the socioeconomic potential of MWCNT is
two-sided (with both benefit and risk), comprehensive
safety studies need to be conducted. For this reason, there
is a further need to investigate the amounts of MWCNT
accumulating in the lungs, the organ most impacted by in-
halation of nanotubules.
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